Cannabinoids and Their Receptors

<p>1. Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays<br>2. Protocols and Good Operating Practices in the Study of Cannabinoid Receptors<br>3. Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP Signaling<br>4. Techniques for the Cellular and Subcellular Localization of Endocannabinoid Receptors and Enzymes in the Mammalian Brain<br>5. Endocannabinoid Transport Proteins: Discovery of Tools to Study Sterol Carrier Protein-2<br>6. Lipidomics: A Corrective Lens for Enzyme Myopia<br>7. Functional Analysis of Mitochondrial CB1 Cannabinoid Receptors (mtCB1) in the Brain<br>8. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies<br>9. Metabolic Profiling of CB1 Neutral Antagonists<br>10. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains<br>11. New Methods for the Synthesis of Cannabidiol Derivatives<br>12. Approaches to Assess Biased Signaling at the CB1R Receptor<br>13. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications<br>14. Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels<br>15. Purification of Functional CB1 and Analysis by Site-Directed Fluorescence Labeling Methods<br>16. Mass Spectrometry Analysis of Human CB2 Cannabinoid Receptor and Its Associated Proteins<br>17. Expression and NMR Structural Studies of Isotopically Labeled Cannabinoid Receptor Type II<br>18. Methods for the Development of In Silico GPCR Models<br>19. Molecular Dynamics Methodologies for Probing Cannabinoid Ligand/Receptor Interaction</p>